Cyclin D1 and D3 expression in vestibular schwannomas

Laryngoscope

Volumn 116, Issue 3, 2006, Pages 423-426

  Neff, Brian A ^a,b,e   Oberstien, Elly ^b   Lorenz, Mark ^b   Chaudhury, Abhik R ^a,b   Welling, D Bradley ^a,b,d   Chang, Long Sheng ^a,b,c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d Mayo Clinic ^*  (United States)

^e MAYO CLINIC   (United States)

Author keywords

And cell cycle; Neurofibromatosis type 2; NF2 gene; Vestibular schwannoma

Indexed keywords

CYCLIN D1; CYCLIN D3; PROTEIN ANTIBODY; CANCER ANTIBODY; CYCLINE; TUMOR MARKER;

ACOUSTIC NEURINOMA; ADULT; ARTICLE; BREAST CARCINOMA; CANCER TISSUE; CELL CYCLE REGULATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NUCLEAR IMPORT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHWANN CELL; SEX RATIO; STAINING; STATISTICAL ANALYSIS; TISSUE SECTION; TUMOR CELL; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VOLUME; VESTIBULAR NERVE; BIOSYNTHESIS; BREAST TUMOR; CARCINOMA; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; METABOLISM; NEUROMA; PATHOLOGY; PROSTATE TUMOR;

ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CARCINOMA; CYCLIN D1; CYCLINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROMA, ACOUSTIC; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645525449     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000195076.05466.6c     Document Type: Article

References (27)

1. Welling DB. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas). Laryngoscope 1998;108:178-189.
2. Lasak JM, Welling DB. Akhmametyeva EM, et al. Retinoblastoma-cyclin- dependent kinase pathway deregulation in vestibular schwannomas. Laryngoscope 2002;112:1555-1561.
3. Welling DB, Lasak JM, Chang LS, et al. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002;23:736-748.
4. Sherr CJ. Cell cycle control and cancer. Harvey Lect 2000-2001;96:73-92.
5. Kim HA, Pomeroy SL, Whoriskey W, et al. A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. Neuron 2000;26 (2):405-416.
6. Kim HA, Ratner N, Roberts TM, et al. Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. J Neurosci 2001;21 (4):1110-1116.
7. Rahmatullah M, Schroering A, Rothblum K, et al. Synergistic regulation of Schwann cell proliferation by heregulin and forskolin. Mol Cell Biol 1998;18:6245-6252.
8. Schworer CM, Masker KK, Wood GC, et al. Microarray analysis of gene expression in proliferating Schwann cells: synergistic response of a specific subset of genes to the mitogenic action of heregulin plus forskolin. J Neurosci Res 2003;73:456-464.
9. Fuentealba L, Schworer C, Schroering A, et al. Heregulin and forskolin-induced cyclin D3 expression in Schwann cells: Role of a CCAAT promoter element and CCAAT enhancer binding protein. Glia 2004;45:238-248.
10. Seto M, Yamamoto K, Iida S, et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 1992;7:1401-1406.
11. Leach FS, Elledge SJ, Sherr CJ, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993;53:1986-1989.
12. Bartkova J, Lukas J, Strauss M, et al. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995;10:775-778.
13. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-4817.
14. Han EK, Lim JT, Arber N, et al. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 1998;35:95-101.
15. Oyama T, Kashiwabara K, Yoshimoto K, et al. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res 1998;58:2876-2880.
16. Sonoki T, Harder L, Horsman DE, et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 2001;98:2837-2844.
17. McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995;11:885-891.
18. Florenes VA, Faye RS, Maelandsmo GM, et al. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin Cancer Res 2000;6:3614-3620.
19. Doglioni C, Chiarelli C, Macri E, et al. Cyclin D3 expression in normal, reactive, and neoplastic tissues. J Pathol 1998;185:159-166.
20. Bartkova J, Lukas J, Muller H, et al. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-361.
21. Mukhopadhyay A, Banerjee S, Stafford LJ, et al. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002;21:8852-8861.
22. Lamb J, Ramaswamy S, Ford HL, et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003;114:323-334.
23. Ewen ME, Lamb J. The activities of cyclin D1 that drive tumorigenesis. Trends Mol Med 2004;10:158-162.
24. Rodriguez-Puebla ML, LaCava M, Miliani DeMarval PL, et al. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia. Am J Pathol 2000;157:1039-1050.
25. Chen Q, Lin J, Jinno S, et al. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 2003;22:992-1001.
26. Bartkova J, Zemanova M, Bartek J. Abundance and subcellular localization of cyclin D3 in human tumors. Int J Cancer 1996;65:323-327.
27. Atonasoski S, Shumas S, Dickson C, et al. Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury. Mol Cell Neurosci 2001;18:581-592.